Use of monoclonal antibody in a blocking ELISA to detect group specific antibodies to bluetongue virus

1984 ◽  
Vol 74 (1) ◽  
pp. 139-149 ◽  
Author(s):  
John Anderson
2019 ◽  
Vol 180 ◽  
pp. 6-8 ◽  
Author(s):  
Karam Chand ◽  
Sanchay Kumar Biswas ◽  
Muthannan Andavar Ramakrishnan

2008 ◽  
Vol 130 (1-2) ◽  
pp. 80-87 ◽  
Author(s):  
Johannes A. Kramps ◽  
Kees van Maanen ◽  
Maria H. Mars ◽  
Johan K. Popma ◽  
Piet A. van Rijn

1990 ◽  
Vol 96 (2) ◽  
pp. 239-248
Author(s):  
E.P. Parrish ◽  
J.E. Marston ◽  
D.L. Mattey ◽  
H.R. Measures ◽  
R. Venning ◽  
...  

Metabolic labelling with [35S]methionine and immunoprecipitation with specific antibodies to bovine desmosomal glycoproteins 2 and 3 (dg2 and dg3: desmocollins) reveals a triplet of polypeptides of Mr 115,000, 107,000 and 104,000 in MDCK cells. Tunicamycin treatment shows that this heterogeneity does not arise through differential N-linked glycosylation. Under conditions in which cells are actively forming desmosomes, the largest polypeptide, dg2, becomes phosphorylated on serine, but the two smaller polypeptides, dg3a and 3b, do not. Controlled trypsinisation of intact cells yields three membrane-protected fragments (Mr 28,000, 24,000 and 23,000) derived from these glycoproteins. The largest of these fragments is phosphorylated but the two smaller fragments are not. A monoclonal antibody to bovine dg2 and dg3 stains MDCK cells cytoplasmically. In immunoblotting of MDCK cells the monoclonal antibody recognises dg2 strongly and shows a weaker reaction with a band of lower Mr corresponding to dg3a. It also recognises the immunoprecipitated 28,000 Mr fragment from trypsinised cells and a smaller fragment of 24,000 Mr. The simplest interpretation of these data is that all three glycoproteins have a transmembrane configuration with a single membrane-spanning domain, and show heterogeneity of size and phosphorylation in their cytoplasmic domains. The data are discussed in relation to the known structures of some cell adhesion molecules. Questions about the relative roles and distributions of the different polypeptides in desmosomal organisation are raised.


1991 ◽  
Vol 29 (7) ◽  
pp. 1466-1471 ◽  
Author(s):  
D D Erdman ◽  
L J Anderson ◽  
D R Adams ◽  
J A Stewart ◽  
L E Markowitz ◽  
...  

1990 ◽  
Vol 36 (1) ◽  
pp. 47-52 ◽  
Author(s):  
G Bugari ◽  
C Poiesi ◽  
A Beretta ◽  
S Ghielmi ◽  
A Albertini

Abstract In this immunoenzymatic assay for human lutropin (hLH) we used bi-specific antibodies (BiAbs) obtained from the fusion of two hybridomas producing antibodies to beta-D-galactosidase and hLh. The BiAb complexed with the enzyme beta-D-galactosidase was used as tracer in a double-determinant assay. We compared the assay involving the BiAb (Bi-EIA) with an immunoenzymatic assay (EIA) in which the same capture antibody was used but the tracer was an enzyme-conjugated hLH-specific monoclonal antibody produced by the same parental cell line used to produce the BiAb. The coefficient of correlation (r) between the two assays was 0.979 but the Bi-EIA was more sensitive (detection limits: 0.8 int. units/L for the Bi-EIA, 2.0 int. units/L for the EIA) and more specific (less than 0.04% vs less than 1.2% cross-reactions with human choriogonadotropin). Mean intra- and interassay CVs for the Bi-EIA were 2.9% and 5.9%, respectively. Correlation (r) with an immunoradiometric assay (IRMA, Serono kit) was 0.960, with radioimmunoassay (RIA, Biodata kit) 0.909, and with an enzyme-linked immunosorbent assay (ELISA kit, Specialty Medical Industries Inc.) 0.888, (n = 25). Evidently, bi-specific antibodies can be used successfully in immunoenzymatic assays, and with potentially greater sensitivity and specificity than assay with a traditional antibody-enzyme conjugate.


1996 ◽  
Vol 25 (4) ◽  
pp. 691-703 ◽  
Author(s):  
G. Czifra ◽  
M. Nilsson ◽  
D. J. Alexander ◽  
R. Manvell ◽  
S. Kecskeméti ◽  
...  

Parasitology ◽  
2000 ◽  
Vol 120 (6) ◽  
pp. 553-564 ◽  
Author(s):  
R. A. SKILTON ◽  
A. J. MUSOKE ◽  
C. W. WELLS ◽  
Y. YAGI ◽  
V. NENE ◽  
...  

Previous studies using monoclonal antibody (mAb) 4C9 specific for a 32 kDa antigen (p32) of Theileria parva demonstrated expression of the antigen on the surface of the sporozoite, making it a potential antigen for sporozoite neutralization. A full-length cDNA encoding the major merozoite/piroplasm surface antigen (mMPSA) of T. parva was cloned and expressed in bacteria. The expressed product reacted strongly with mAb 4C9, demonstrating identity between the p32 and mMPSA of T. parva. Using immunoblot analysis and immunoelectron microscopy with mAb 4C9 it was shown that the mMPSA is a major antigen of the merozoite and piroplasm at the cell surface, while lower levels of antigen are expressed in the sporozoite and schizont stages. Upregulation of the mMPSA occurs at merogony and can be induced by culturing schizont-infected lymphocytes at 42 °C. Recombinant mMPSA of T. parva induced high titres of specific antibodies in cattle but failed to confer protection against a T. parva sporozoite stabilate challenge. The pre-challenge sera also failed to neutralize infectivity of sporozoites in an in vitro assay. Possible reasons for the lack of parasite neutralization in vivo and in vitro are discussed.


1987 ◽  
Vol 18 (4) ◽  
pp. 271-279 ◽  
Author(s):  
Ahmad Afshar ◽  
Frederick C. Thomas ◽  
Peter F. Wright ◽  
Janet L. Shapiro ◽  
John Anderson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document